Expert Opinion on Emerging Drugs
About
The 848 papers published in Expert Opinion on Emerging Drugs in the last decades have received a total of 14.7k indexed citations.
Papers published in Expert Opinion on Emerging Drugs usually cover Molecular Biology (187 papers), Oncology (168 papers) and Pulmonary and Respiratory Medicine (137 papers) specifically the topics of Lung Cancer Treatments and Mutations (29 papers), Chronic Lymphocytic Leukemia Research (27 papers) and HER2/EGFR in Cancer Research (26 papers). The most active scholars publishing in Expert Opinion on Emerging Drugs are Cesare Gridelli, Paolo Martelletti, Fortunato Ciardiello, Gordon S. Lynch and Francis J. Giles.
In The Last Decade
Fields of papers published in Expert Opinion on Emerging Drugs
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries where authors publish in Expert Opinion on Emerging Drugs
Since SpecializationTotal citations of papers
Explore journals with similar magnitude of impact
Breakdown of academic impact, for papers in Advanced Sustainable Systems Breakdown of academic impact, for papers in American Journal of Cardiovascular Drugs Breakdown of academic impact, for papers in Biological Research For Nursing Breakdown of academic impact, for papers in Elementa Science of the Anthropocene Breakdown of academic impact, for papers in The Photogrammetric Record Breakdown of academic impact, for papers in Time & Society Breakdown of academic impact, for papers in Clinical EEG and Neuroscience Breakdown of academic impact, for papers in Atomization and Sprays